Nauka
Analiza porównawcza toksyczności środków konserwujących w preparatach okulistycznych
11 minut
Piśmiennictwo
- Baudouin C, Labbe A, Liang H, Pauly A, Brignole-Baudouin F. Preservatis in eye drops: the good, the bad and the ugly. Prog Ret Eye Res 2010; 4:312-334.
- Burstein NL. Corneal cytotoxicity of topically applied drugs, vehicles and preservatives 1980; 1: 15-30.
- Epstein SP, Ahdoot M, Marcus E, Asbell PA. Comparative toxicity of preservatives on immortalized corneal and conjuctival epithelial cells. J Ocular Pharm Ther 2009; 2: 113-119.
- Herrero VR. Preservatives in ophthalmic formulations: an overview. Arch Soc Esp Oftalmol 2007ł 82Ł531+532.
- Kahook MZ, Fechtner RD, Katy LJ, Noecker RJ, Ammar DA. A comparison of active ingredients and preservatives between brand name and generic topical glaucoma medications using liquid chromatographz+tandem mass spektrometry. Curr Eye Res 2012; 37: 101-108.
- Su KR and Jessen BA. Evaluation of the cytotoxic effects of ophthalmic solutions containing benzalkonium chloride on corneal epithelium using an organotypic 3-D model. BMC Ophtalmology 2009; 9: 5.
- Kluk A, Sznitowska M. Substancje pomocnicze w lekach do oczu. Technologia Postaci Leku 2010, 8, 567-572.
- Koevary SB. Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyond. Curr Drug Metab 2003; 4: 213-222.
- Paimela T, Ryhanen T, Kauppinen A et al. The preservative polyquaternium-1 increases cytoxicity and NF-kappa B linked inflammation in human corneal epithelial cells. Mol Vision 2012; 18: 1189-1196.
- Zore M, Harris A, Tobe LA et al. Generic medications in ophthalmology. Br J Ophtalmol 2012; 0: 1-5.doi:10.1136.